- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 20, 2026 | 121.24M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 93.73M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 27.52M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.97M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.55M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $10M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.18M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $51.47M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $9.46M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $755.97K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.19M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $553.74K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $76.76K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.27M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $129.76K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $10.93M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $7.29M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $59.74M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.59M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.15 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.15 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.21M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $850.28K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $321.27K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$13.86M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$2.12M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$9.51M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.59M |